Attached files

file filename
8-K - FORM 8-K - Nutrastar International Inc.form8k.htm

Nutrastar International Inc. Announces Second Quarter 2015 Results

Harbin, China, August 13, 2015 -- Nutrastar International Inc. (OTC: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris (“Cordyceps”), functional health beverages and organic and specialty foods, today announced its results for the three months and six months ended June 30, 2015.

Financial Highlights for the Three Months Ended June 30, 2015

  Net revenue was $13.24 million, representing an increase of $0.24 million or 1.8% from $13.00 million in the comparable 2014 three month period.
  Gross profit was $10.32 million, representing a gross margin of 77.9%.
  Net income was $7.08 million, representing a net margin of 53.4%.
  Basic and diluted EPS were $0.41 and $0.40, respectively, with 16.99 million basic shares and 17.74 million diluted shares outstanding.

Financial Highlights for the Six Months Ended June 30, 2015

  Net revenue was $20.29 million, representing an increase of $0.41 million or 2.0% from $19.87 million in the comparable 2014 six month period.
  Gross profit was $15.78 million, representing a gross margin of 77.8%.
  Net income was $10.61 million, representing a net margin of 52.3%.
  Basic and diluted EPS were $0.62 and $0.60, respectively, with 16.98 million basic shares and 17.74 million diluted shares outstanding.

Management Commentary

Ms. Lianyun Han, CEO of Nutrastar, commented, “For the first half of 2015, we performed in line with our expectations. Sales of our core premium consumer product Cordyceps came in at $17.29 million, up 3.1% year-over-year, functional health beverages contributed $1.83 million and organic and specialty foods segment, our third consumer product category, contributing $1.17 million to revenues. Gross margin expanded in the first half of the year by 0.9% to 77.8% as a result of economics of scale and an attractive product mix. Overall, we’re delighted with the outcome of the second quarter and first six months of the year – both periods marked by continued strong margins and an overall increase in revenue thanks to continued Cordyceps demand.”

Ms. Han continued, “As for the remainder of the year, we are confident in the continuation of our growth and expect to meet our full year 2015 revenue guidance. Demand for our premium consumer products remains steadfast and robust. We remain committed to growing our brand awareness, bringing more products into the hands of health-conscious consumers and expanding our market internationally.”


“As far as composition of our Board of Directors, after the resignation of Mr. Zhang Chunming due to personal health reasons, the Board currently comprised of six members, four of whom are independent directors. I would like to thank Mr. Zhang for his service over the past few years and wish him well in his future endeavors. The Company has started the recruitment process of a new director to fulfill the vacancy. We expect bringing on someone who can assist the Company in areas of product development and market expansion,” added Ms. Han.

Outlook for the Year Ending December 31, 2015

Based on management’s current expectations, full year 2015 revenue remains in the range of $43 million to $45 million.

For more information regarding Nutrastar’s financial performance during the three and six months ended June 30, 2015, please refer to the Quarterly Report on Form 10-Q to be filed with the Securities and Exchange Commission on or about August 13, 2015.

About Nutrastar International Inc.

Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 336 employees, including 21 in R&D, and 149 in sales and marketing. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: ir@nutrastarintl.com

Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at: http://www.nutrastarintl.com/alerts

Safe Harbor Statement

This news release contains “forward-looking statements” relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.


For more information, please contact:

Investor Relations
Tel: 408-368-0254
Email: ir@nutrastarintl.com


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(Unaudited)
(AMOUNTS EXPRESSED IN US DOLLARS)

 

  For the Three Months     For the Six Months  

 

  Ended June 30,     Ended June 30,  

 

  2015     2014     2015     2014  

NET REVENUE

$  13,243,223   $  13,004,562   $  20,285,550   $  19,871,243  

Cost of goods sold

  (2,921,381 )   (2,953,060 )   (4,505,641 )   (4,581,314 )

GROSS PROFIT

  10,321,842     10,051,502     15,779,909     15,289,929  

Selling expenses

  (427,661 )   (478,832 )   (725,286 )   (725,895 )

General and administrative expenses

  (594,449 )   (533,618 )   (1,085,732 )   (1,206,633 )

Income from operations

  9,299,732     9,039,052     13,968,891     13,357,401  

Other income (expenses):

                       

   Interest income

  114,822     97,226     226,229     189,084  

   Foreign exchange differences

  6,240     (1,639 )   (1,831 )   (19,728 )

   Total other income

  121,062     95,587     224,398     169,356  

Income before income taxes

  9,420,794     9,134,639     14,193,289     13,526,757  

Provision for income taxes

  (2,342,967 )   (2,338,917 )   (3,584,285 )   (3,497,461 )

NET INCOME

  7,077,827     6,795,722     10,609,004     10,029,296  

OTHER COMPREHENSIVE INCOME:

                       

   Foreign currency translation adjustments

  674,919     (17,913 )   149,745     (1,070,742 )

COMPREHENSIVE INCOME

$  7,752,746   $  6,777,809   $  10,758,749   $  8,958,554  

Earnings per share:

                       

   Basic

$  0.41   $  0.40   $  0.62   $  0.59  

   Diluted

$  0.40   $  0.38   $  0.60   $  0.57  

Weighted average number of shares outstanding:

                       

   Basic

  16,996,396     16,858,667     16,977,221     16,758,599  

   Diluted

  17,739,156     17,694,270     17,738,285     17,657,471  


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(AMOUNTS EXPRESSED IN US DOLLARS)

 

  June 30, 2015     December 31, 2014  

 

  (Unaudited)        

ASSETS  

           

CURRENT ASSETS

           

 Cash and cash equivalents

$  137,730,508   $  126,542,564  

 Accounts receivable

  95,620     93,066  

 Inventories

  922,555     635,409  

 Prepayments and other receivables

  1,706,928     1,489,800  

   Total current assets

  140,455,611     128,760,839  

OTHER ASSETS

           

 Intangible assets, net

  368,430     613,315  

 Property, plant and equipment, net

  13,944,027     14,424,942  

 

           

   Total assets

$  154,768,068   $  143,799,096  

 

           

LIABILITIES AND STOCKHOLDERS' EQUITY 

           

CURRENT LIABILITIES

           

 Other payables and accruals

$  954,724   $  990,290  

 Taxes payable

  2,899,998     2,748,583  

 Due to a related party

  524,212     511,054  

 Preferred stock dividend payable

  742,778     690,662  

   Total current liabilities

  5,121,712     4,940,589  

   Total liabilities

  5,121,712     4,940,589  

COMMITMENTS AND CONTINGENCIES

           

STOCKHOLDERS' EQUITY

           

  Preferred Stock, $0.001 par value, 1,000,000 shares authorized, 74,276 shares and 77,776 shares issued and outstanding at June 30, 2015 and December 31, 2014, respectively; aggregate liquidation preference amount: $2,079,728 and $ 2,177,728, plus accrued but unpaid dividend of $742,778 and $690,662, at June 30, 2015 and December 31, 2014, respectively

  1,693,950     1,773,772  

  Common stock, $0.001 par value, 190,000,000 shares authorized, 17,039,951 shares issued and 16,996,396 shares outstanding at June 30, 2015; 16,953,541 shares issued and 16,909,986 shares outstanding at December 31, 2014

  17,040     16,954  

 

           

 Additional paid-in capital

  21,315,259     21,122,372  

 Statutory reserves

  4,989,033     4,989,033  

Treasury stock, at cost, 43,555 shares as of June 30, 2015 and December 31,2014

  (78,767 )   (78,767 )

 Retained earnings

  113,308,261     102,783,308  

 Accumulated other comprehensive income

  8,401,580     8,251,835  

   Total stockholders' equity

  149,646,356     138,858,507  

 

           

   Total liabilities and stockholders' equity

$  154,768,068   $  143,799,096  


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(AMOUNTS EXPRESSED IN US DOLLARS)

 

  For the Six Months Ended June 30,  

 

  2015     2014  

CASH FLOWS FROM OPERATING ACTIVITIES:

           

Net income

$  10,609,004   $  10,029,296  

Adjustments to reconcile net income to cash provided by operating activities:

           

   Depreciation and amortization

  737,238     743,052  

   Share-based compensation expense

  81,216     66,463  

   IR unregistered stock compensation expense

  -     53,371  

(Increase) decrease in assets:

           

           Accounts receivable

  (2,466 )   (37,370 )

           Inventories

  (285,869 )   (136,651 )

           Prepayments and other receivables

  (215,274 )   (68,381 )

Increase (decrease) in liabilities:

           

           Other payables and accruals

  (36,264 )   (127,833 )

           Advance from related party

  -     179,980  

           Taxes payable

  148,615     (46,908 )

     Net cash provided by operating activities

  11,036,200     10,655,019  

 

           

 

           

CASH FLOWS FROM FINANCING ACTIVITIES:

           

   Advance from related party

  10,951     29,704  

     Net cash provided by financing activities

  10,951     29,704  

 

           

Foreign currency translation adjustment

  140,793     (960,635 )

 

           

INCREASE IN CASH AND CASH EQUIVALENTS

  11,187,944     9,724,088  

CASH AND CASH EQUIVALENTS, at the beginning of the period

  126,542,564     102,599,186  

 

           

CASH AND CASH EQUIVALENTS, at the end of the period

$  137,730,508   $  112,323,274  

 

           

NON-CASH TRANSACTIONS

           

Preferred stock and dividend converted into common stock

$  111,757   $  958,897  

Preferred stock dividend payable

  84,051     88,249  

Share-based payment to officers and directors under equity incentive plan

  81,216     66,463  

Share-based payment – IR unregistered stock compensation expense

  -     53,371  

SUPPLEMENTAL DISCLOSURE INFORMATION

           

Income taxes paid

$  3,494,213   $  3,502,450